Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$140K
Filings
13
Firms Hired
1
Active Period
2016–2018
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017 Medicare Part D biosimilars
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 2051
Prescription drug pricing S. 974 - CREATES Act S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017 Medicare Part D biosimilars
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 2051
Fair Accountability and Innovative Research Drug Pricing Act of 2017
2017 · fourth_quarter · Firm: NCHC ACTION FUND
Prescription drug pricing S. 974 - CREATES Act S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017 Medicare Part D biosimilars
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 2439
Fair Accountability and Innovative Research Drug Pricing Act of 2017
2017 · fourth_quarter · Firm: NCHC ACTION FUND
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017 Medicare Part D biosimilars
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 2439
Fair Accountability and Innovative Research Drug Pricing Act of 2017
2017 · fourth_quarter · Firm: NCHC ACTION FUND
Prescription drug pricing S. 974 - CREATES Act S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017 Medicare Part D biosimilars
Client expense: $10,000 · Firm income: —
Matched citations: S. 1131
Fair Accountability and Innovative Research Drug Pricing Act of 2017
2017 · fourth_quarter · Firm: NCHC ACTION FUND
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017 Medicare Part D biosimilars
Client expense: $10,000 · Firm income: —
Matched citations: S. 1131
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
2017 · fourth_quarter · Firm: NCHC ACTION FUND
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017 Medicare Part D biosimilars
Client expense: $10,000 · Firm income: —
Matched citations: S. 974
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
2017 · fourth_quarter · Firm: NCHC ACTION FUND
Prescription drug pricing S. 974 - CREATES Act S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017 Medicare Part D biosimilars
Client expense: $10,000 · Firm income: —
Matched citations: S. 974
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 2051
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 2051
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 2430
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 2430
Fair Accountability and Innovative Research Drug Pricing Act of 2017
2017 · third_quarter · Firm: NCHC ACTION FUND
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 2439
Fair Accountability and Innovative Research Drug Pricing Act of 2017
2017 · third_quarter · Firm: NCHC ACTION FUND
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 2439
Fair Accountability and Innovative Research Drug Pricing Act of 2017
2017 · third_quarter · Firm: NCHC ACTION FUND
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $10,000 · Firm income: —
Matched citations: S. 1131
Fair Accountability and Innovative Research Drug Pricing Act of 2017
2017 · third_quarter · Firm: NCHC ACTION FUND
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $10,000 · Firm income: —
Matched citations: S. 1131
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $10,000 · Firm income: —
Matched citations: S. 934
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $10,000 · Firm income: —
Matched citations: S. 934
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
2017 · third_quarter · Firm: NCHC ACTION FUND
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $10,000 · Firm income: —
Matched citations: S. 974
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
2017 · third_quarter · Firm: NCHC ACTION FUND
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $10,000 · Firm income: —
Matched citations: S. 974
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 2051
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 2051
FDA Reauthorization Act of 2017
2017 · second_quarter · Firm: NCHC ACTION FUND
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 2430
FDA Reauthorization Act of 2017
2017 · second_quarter · Firm: NCHC ACTION FUND
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 2430
Fair Accountability and Innovative Research Drug Pricing Act of 2017
2017 · second_quarter · Firm: NCHC ACTION FUND
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 2439
Source: Senate LDA